PranaX Corporation, a pioneer in exosome-based regenerative wellness, has appointed Phillip Maderia as its new Chief Executive Officer. Maderia boasts over three decades of leadership in biopharmaceutical manufacturing, most notably in pioneering exosome production. He joins PranaX from Lonza, where he served as Site Head and exosome Business Leader of the Lexington, MA, manufacturing facility since 2021. At Lonza, he spearheaded the expansion of the exosome business, overseeing a $12M ope...